Rituximab and Checkpoint Inhibitors: A New Strategy to Prevent Immune-Related Toxicity

Coverage, in order

1. 11h ago
   
   OncoDaily obscure

   Rituximab and Checkpoint Inhibitors: A New Strategy to Prevent Immune-Related Toxicity

   Combination immune checkpoint blockade has transformed the treatment of advanced melanoma, but its clinical success comes with a persistent challenge: the immune activation responsible for tumor regression can also cause

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.